This article discusses the release of a dataset containing clinical, cognitive, and MRI data from a study on the use of rTMS as a treatment for cocaine use disorder. The dataset has been used in various studies and offers the opportunity for further analysis and testing of new neuroimaging algorithms and techniques. The study was conducted at the National Institute of Psychiatry in Mexico City and was approved by the Ethics Committee.
